Table 2.

Therapeutic usage* among patients with psoriatic arthritis by drug class

Drug classification	Psoriatic arthritis population (n=94 302)
	n†	%
Biologics‡	31 308	33.20
DMARDs§	38 099	40.40
NSAIDs	43 194	45.80
Steroids	56 915	60.35

*Treatments used on or after the index date (first diagnosis of psoriatic arthritis).

†Number of patients who received one or more therapies. Patients who received more than one therapy are included for each therapy class received.

‡Also known as biologic DMARDs.

§Include conventional oral DMARDs, including conventional synthetic DMARDs and the targeted synthetic DMARDs tofacitinib and apremilast.

DMARDs, disease-modifying antirheumatic drugs; NSAIDs, non-steroidal anti-inflammatory drugs.